Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
Flomenberg Neal (CIK 2011757) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-17). Recent activity: Sell TVGN (19 shares), Sell TVGN (452 shares), Sell TVGN (501 shares), Buy TVGN (300,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-17 | Tevogen Bio Holdings Inc. (TVGN) | Chief Scientific Officer, Global R&D Lead. All holdings herein have been adjusted to reflect the Company's 1-for-50 reverse stock split effected on March 6, 2026 | Sell | 19 | $147 |
| 2026-03-17 | Tevogen Bio Holdings Inc. (TVGN) | Chief Scientific Officer, Global R&D Lead. All holdings herein have been adjusted to reflect the Company's 1-for-50 reverse stock split effected on March 6, 2026 | Sell | 452 | $3,282 |
| 2026-03-17 | Tevogen Bio Holdings Inc. (TVGN) | Chief Scientific Officer, Global R&D Lead. All holdings herein have been adjusted to reflect the Company's 1-for-50 reverse stock split effected on March 6, 2026 | Sell | 501 | $3,206 |
| 2025-07-01 | Tevogen Bio Holdings Inc. (TVGN) | Chief Scientific Officer, Global R&D Lead | Buy | 300,000 | $0 |
Source: SEC Form 4 filings · as of 2026-03-17